WE INVESTIGATE HOW PHYSICAL INTERACTIONS AND FORCE TRANSMISSION BETWEEN CELLS AND THEIR SURROUNDING MATRIX REGULATE TUMOR PROGRESSION AND THE IMMUNE RESPONSE IN CANCER.

Our research focuses on understanding how cellular mechanosensing influences cell motility, communication, and fate.

To explore these mechanisms, we develop advanced 2D and 3D on-chip models that recapitulate the physical constraints, composition, and spatial organization of tissues and tumors. These microengineered systems enable us to dissect how stromal and tumor cells migrate, interact, and adapt to mechanical cues in physiologically relevant contexts.

By integrating biophysical, cellular, and engineering approaches, our goal is to uncover how mechanical signals drive disease progression and to identify novel mechanobiological pathways that can be targeted to prevent or treat cancer and other pathologies.

Our group actively collaborates with academic, clinical, and industrial partners to design innovative on-chip platforms for studying cell mechanics across diverse physiological and pathological settings.

PRESENTATION

GET TO KNOW US BETTER

  • Own scientific image of the laboratory
  • Own scientific image of the laboratory

RESEARCH STAFF

THE PEOPLE WHO MAKE IT ALL POSSIBLE

Anna Labernadie 
alabernadie@cipf.es

Maria Paz Rubio Rodriguez
mprubio@cipf.es

Virginia Llopis Hernández
vllopish@cipf.es

Julie Buisson 
jbuisson@cipf.es

Ana Ferrero Micó
aferrero@cipf.es

PUBLICATIONS

OUR SCIENTIFIC CONTRIBUTIONS

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Perucca A, Llonín AG, Benach OM, Hallopeau C, Rivas EI, Linares J, Garrido M, Sallent-Aragay A, Golde T, Colombelli J, Dalaka E, Linacero J, Cazorla M, Galan T, Pastor Viel J, Badenas X, Recort-Bascuas A, Comerma L, Fernandez-Nogueira P, Rovira A, Roca-Cusachs P, Albanell J, Trepat X, Calon A and Labernadie A

Nature Communications 2025 Feb,  DOI:  10.1038/s41467-025-56275-1,  Vol. 16,  pag. 1279-1279

READ PUBLICATION

Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells.

Conti S, Venturini V, Cañellas-Socias A, Cortina C, Abenza JF, Stephan-Otto Attolini C, Middendorp Guerra E, Xu CK, Li JH, Rossetti L, Stassi G, Roca-Cusachs P, Diz-Muñoz A, Ruprecht V, Guck J, Batlle E, Labernadie A and Trepat X

Nature Communications 2024 Apr,  DOI:  10.1038/s41467-024-47227-2,  Vol. 15,  pag. 3363-3363

READ PUBLICATION

Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.

Rivas EI, Linares J, Zwick M, Gómez-Llonin A, Guiu M, Labernadie A, Badia-Ramentol J, Lladó A, Bardia L, Pérez-Núñez I, Martínez-Ciarpaglini C, Tarazona N, Sallent-Aragay A, Garrido M, Celià-Terrassa T, Burgués O, Gomis RR, Albanell J and Calon A

Nature Communications 2022 Sep,  DOI:  10.1038/s41467-022-32782-3,  Vol. 13,  pag. 5310-5310

READ PUBLICATION

CAFs and Cancer Cells Co-Migration in 3D Spheroid Invasion Assay.

Conti S, Kato T, Park D, Sahai E, Trepat X and Labernadie A

Methods In Molecular Biology 2021 Jan,  DOI:  10.1007/978-1-0716-0779-4_19,  Vol. 2179,  pag. 243-256

READ PUBLICATION

A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion.

Labernadie A, Kato T, Brugués A, Serra-Picamal X, Derzsi S, Arwert E, Weston A, González-Tarragó V, Elosegui-Artola A, Albertazzi L, Alcaraz J, Roca-Cusachs P, Sahai E and Trepat X

NATURE CELL BIOLOGY 2017 Mar,  DOI:  10.1038/ncb3478,  Vol. 19,  pag. 224-237

READ PUBLICATION

FUNDING

THANK YOU FOR SUPPORTING US